• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Eugia Pharma Generic Tirofiban Hydrochloride Receives Approval in the U.S

    FDA

    Medicure Announces that the Shortened AGGRASTAT® Versus INTEGRILIN®

    PRNEWSWIRE

    Medicure Announces Early Completion of Enrollment for Ispasm

    PRNEWSWIRE

    MEDICURE ANNOUNCES EARLY COMPLETION OF ENROLLMENT FOR ISPASM, A PHASE 1/2A

    MEDICURE

    Medicure Announces AGGRASTAT® Shows Promise in Treating Thrombotic Complications

    PRNEWSWIRE

    Correvio partners with Teson for commercializing cardiac drug in China

    BIOSPECTRUMASIA

    Medicure Files Patent Infringement Action

    PR NEWSWIRE

    FDA Confirms Paragraph IV Patent Challenge ofAggrastat 20913(Tirofiban) Hydrochloride Injection 12.5 mg/250 Ml & 5 mg/100 mL

    FDA

    Medicure Files Patent Infringement Action

    PR NEWSWIRE

    Cipher Pharmaceuticals and Cardiome Pharma Announce Strategic Transaction for Canadian Business Portfolio of Cardiome

    PR NEWSWIRE

    Medicure Acquires Exclusive License to Sell & Market Branded Cardio Drug U.S.

    PR NEWSWIRE

    Medicure Announces Filing of ANDA in Collaboration with Apicore

    PR NEWSWIRE

    Medicure Announces Filing of sNDA for New AGGRASTAT® Indication

    PR NEWS WIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.